Abstract

Objective: Pityriasis rosea (PR) is a self-limited, common, acute papulosquamous disease that frequently affects the trunk and extremities. It typically affects children and young adults. It is rare under ten years of age. There are few studies on PR seen in children. We therefore aimed to investigate the clinical course and characteristics of PR in children.

Material and Methods: This is a retrospective study of 67 children aged 6 months to 16 years who presented to the dermatology outpatient clinic and were diagnosed as PR with  the clinical and/or histopathologic findings.

The patients were examined in terms of age, gender, location of lesions, plaque presence, itching, duration of complaints, presence of upper respiratory tract infection or prodromal symptoms, family history, atopy history, and drug history.

Results: The age of the 67 children included in the study ranged from 6 months to 16 years, with an average age of 9.22 and a peak age of 11 (17.9%). There were 29 male (43.3%) and 38 (56.7%) female patients. There were 36 (53.7%) patients under 10 years of age and 10 patients (14.9%) under 4 years of age. Four patients (6%) had atopy, and the duration of disease ranged from 3 days to 4 months (mean 17 days). The interval between the leading lesion and the secondary lesion ranged from 3 days to 1 month (mean 9 days). The lesions were most frequently seen in the trunk.

There were 4 cases (6%) of upper respiratory tract infection prior to the disease. The most common season for the occurrence of the disease was autumn (24 patients, 35.8%). A medallion plaque was observed in 97% of the cases and was localized most frequently on the body. The number of patients with atypical PR was 13 (19.4%) (5 localized, one papulovesicular, one with dual medallions, 6 persistent).






Conclusion: Adult and child PR is not very different clinically.

Keywords: Atypical, Child

References

  1. 1. Drago F, Ciccarese G, Broccolo F, Cozzani E, Parodi A. Pityriasis
  2. rosea in children: Clinical features and laboratory investigations.
  3. Dermatology 2015;231:9–14.
  4. 2. Lemster N, Neumark M, Ingber A. Pityriasis rosea in a woman and
  5. her husband – case report and review of the literature. Case Rep
  6. Dermatol 2010;2:135–9.
  7. 3. Kempf W, Adams V, Kleinhans M, Burg G, Panizzon RG,
  8. Campadelli-Fiume G, et al. Pityriasis rosea is not associated with
  9. human herpesvirus 7. Arch Dermatol 1999;135:1070–2.
  10. 4. Kosuge H, Tanaka-Taya K, Miyoshi H, Amo K, Harada R, Ebihara
  11. T, et al. Epidemiological study of human herpesvirus-6 and human
  12. herpesvirus-7 in pityriasis rosea. Br J Dermatol 2000;143:795–8.
  13. 5. Chuh A, Zawar V, Law M, Sciallis G. Gianotti-Crosti syndrome,
  14. pityriasis rosea, asymmetrical periflexural exanthem, unilateral
  15. mediothoracic exanthem, eruptive pseudoangiomatosis, and
  16. papular-purpuric gloves and socks syndrome: A brief review and
  17. arguments for diagnostic criteria. Infectious Disease Reports 2012;
  18. 4:e12.
  19. 6. Kilinc F, Akbas A, Sener S, Aktas A. Atypical pityriasis rosea: Clinical
  20. evaluation of 27 patients. Cutan Ocul Toxicol 2017;36:157–62.
  21. 7. Balcı DD, Hakverdi S. Vesicular pityriasis rosea: An atypical
  22. presentation. Dermatol Online J 2008;14:6.
  23. 8. Stulberg DL, Wolfrey J. Pityriasis rosea. Am Fam Physician
  24. 2004;69:87-94.
  25. 9. Başkan EB, Turan H, Ercan İ, Yazıcı S, Özkaya G, Sarıcaoğlu
  26. H. Pitriyazis rozea olgularında demografik özellikler ve iklimsel
  27. faktorlerin incelenmesi. Turkderm 2011;45:97-9.
  28. 10. Harman M, Aytekin S, Akdeniz S, Inalöz HS. An epidemiological
  29. study of pityriasis rosea in the Eastern Anatolia. Eur J Epidemiol
  30. 1998;14:495-7.
  31. 11. Adhicari P, Das S. A hospital-based clinical study of pityriasis rosea
  32. in children. J Evid Based Med Healthc 2017;4:365-7.
  33. 12. Drago F, Broccolo F, Rebora A. Pityriasis rosea: An update with
  34. a critical appraisal of its possible herpesviral etiology. J Am Acad
  35. Dermatol 2009;61:303-18.
  36. 13. Mahajan K, Relhan V, Relhan AK, Garg VK. Pityriasis rosea: An
  37. update on etiopathogenesis and management of difficult aspects.
  38. Indian J Dermatol 2016;61:375-84.
  39. 14. Akbaş A, Kılınç F, Yakut Hİ, Metin A. Çocuklarda dermatolojik
  40. hastalıklar: 4025 hastanın prospektif analizi. Türkiye Çocuk Hast
  41. Derg 2015;1:6-11.
  42. 15. Urbina F, Das A, Sudy E. Clinical variants of pityriasis rosea. World
  43. J Clin Cases 2017; 5: 203-11.
  44. 16. Gündüz O, Ersoy-Evans S, Karaduman A. Childhood pityriasis
  45. rosea. Pediatr Dermatol 2009;26:750-1.
  46. 17. Çölgeçen E, Kader Ç, Ulaş Y, Öztürk P, Küçük Ö, Balcı M. Pityriasis
  47. rosea: A natural history of pediatric cases in the Central Anatolia
  48. Region of Turkey. Turk J Med Sci 2016;46:1740-2.
  49. 18. Oğrum A. Unilateral pityriasis rosea in a child: A rare clinical
  50. presentation. Turk J Pediatr 2017;59: 214-6.
  51. 19. Ermertcan AT, Özgüven A, Ertan P, Bilaç C, Temiz P. Childhood
  52. Pityriasis rosea inversa without herald patch mimicking cutaneous
  53. mastocytosis. Iran J Pediatr 2010;20: 237-41.
  54. 20. Balcı DD, Doğramacı ÇA, Çelik E, Yaldız M, Akansu B. Invers
  55. pitriyazis rozea: Nadir bir varyant. Dirim Tıp Gazetesi 2009;84:133-
  56. 7.
  57. 21. Ciccarese G, Parodi A, Drago F. Pediatric pityriasis rosea. Turk J
  58. Med Sci 2017;47:1302-5.
  59. 22. Karasatı S, Toğral AK, Akoğuz ÖÖ, Ekşioğlu M. Üçüncü basamak
  60. bir sağlık kuruluşunda 1 yıl içinde pitiriyazis rozea tanısı alan
  61. hastaların demografik ve klinik özellikleri. Turk J Dermatol 2015;1:
  62. 8-11.

How to cite

1.
Kılınç F. Pityriasis Rosea in Children. Turk J Pediatr Dis [Internet]. 2019 Sep. 23 [cited 2025 May 24];13(5):379-81. Available from: https://turkjpediatrdis.org/article/view/577